Serum levels of vitamin D do not appear to affect in-vitro fertilization (IVF) outcomes such as clinical pregnancy, live birth, and ongoing pregnancy rates, according to the results of a meta-analysis.
No baseline clinical factor is predictive of treatment success in women receiving medical management with misoprostol for early pregnancy loss, according to a study. However, the addition of mifepristone seems to improve treatment success.
A low-intensity, high-coverage intervention delivered through the public healthcare system under standard operating conditions is effective in reducing gestational weight gain (GWG) and shows potential for successful scale-up, a Chilean study has shown.
Thyroid dysfunction during pregnancy is associated with several neurocognitive outcomes in the offspring, suggest the results of a study. Prompt examination and treatment on thyroid function is urged for pregnant women.
Women with recurrent pregnancy loss (RPL) appear to have markedly lower serum ferritin levels compared with those who have no known fertility problem, suggesting that iron status is associated with the severity of reproductive disturbance in women with RPL, according to a study.
NT-814, an oral, non-hormonal dual neurokinin 1,3 receptor antagonist may reduce the frequency of hot flashes, while improving quality of life (QoL) and sleep in postmenopausal women, according to results of the phase IIb SWITCH-1 trial presented at NAMS 2020.